{
  "bio": [
    "Jean-Paul Clozel and his wife Martine Clozel cofounded Swiss biotech firm Actelion in 1997 with three other colleagues.",
    "The husband-and-wife team sold the company to Johnson & Johnson for $30 billion in 2017.",
    "Actelion makes drugs for orphan diseases, which affect fewer than 200,000 people\r\nand typically receive little research funding.",
    "Following the Johnson & Johnson acquisition, the couple spun out publicly-traded Idorsia, which they now run together.",
    "Idorsia is specializing in the discovery and development of small molecules to eventually develop drugs to treat insomnia, lupus and other diseases."
  ],
  "about": [
    "To start Actelion, the Clozels reportedly sold their house and worked out of a rented garage in the company's early days.",
    "Jean-Paul is a trained cardiologist and Martine is a trained pediatrician."
  ]
}